Weekly BioML Digest [August 17, 2026]

Share
Weekly BioML Digest [August 17, 2026]

Machine Learning × Computational Biology paper compilation

Hey! It's your weekly digest of machine learning papers in CompBio and Drug Discovery.

Feedback? Email me at biomldigest@gmail.com.

📚 Peer-Reviewed Journals (Top 20)

1322 matched filters -> 20 selected after LLM relevance + novelty ranking.

🧬 Preprints (arXiv + bioRxiv)

60 matched filters -> 20 selected after LLM relevance + novelty ranking.

  • 🧬 SpatialAgent: An Autonomous AI Agent for Spatial Biology
    Wang, H.; He, Y.; Coelho, P. P.; Bucci, M.; ...; Copping, R.; Rozenblatt-Rosen, O.; Leskovec, J.; Regev, A. — bioRxiv, 2026-08-12
    Introduces an autonomous LLM-based agent for spatial biology that plans, executes, and verifies full analysis loops (panel design, annotation, trajectory, CCI), outperforming baselines and guiding a successful 100-gene Xenium add-on panel in mouse prostate cancer.
    Affiliations: Genentech, Stanford

  • 🧬 PARNET: A CLIP-SEQ-BASED FOUNDATION MODEL FOR RNA SEQUENCE REPRESENTATION LEARNING
    Moyon, L.; Tirabassi, A.; Baranowskii, A.; Capitanchik, C.; ...; Gagneur, J.; Ule, J.; Horlacher, M.; Marsico, A. — bioRxiv, 2026-08-13
    Presents Parnet, a CLIP-seq–trained multi-task foundation model that predicts base-resolution RBP binding from sequence and yields general-purpose embeddings that match or exceed larger self-supervised RNA/genomic LMs across diverse downstream tasks with mechanistic interpretability.
    Affiliations: Computational Health Center, Helmholtz Center Munich; Cluster for Nucleic acid Sciences and Technologies - NUCLEATE, Munich

  • 🧬 PerturbLDM: conditional latent diffusion for modelling single-cell perturbation responses
    Yu, L.; Hsieh, K.-L.; Chu, Y.; Lan, Q.; ...; Zhi, D.; Zhao, Z.; Jiang, X.; Dai, Y. — bioRxiv, 2026-08-16
    Develops a conditional latent diffusion model (PerturbLDM) to generate single-cell transcriptional responses to drugs/doses/cell lines, pretrained on Tahoe-100M and outperforming state-of-the-art across thousands of held-out perturbation-context combinations.
    Affiliations: University of Texas health science center at Houston

  • 🧬 Physically Grounded Generative Modeling of All-Atom Biomolecular Dynamics
    Feng, B.; Zhang, J.; Zhang, X.; Cao, H.; Zhang, M.; Barth, P.; Liu, Z.; Li, Y. — bioRxiv, 2026-08-15
    BioKinema is a physically grounded spatiotemporal diffusion model that generates continuous-time all-atom biomolecular trajectories with correct thermodynamics/kinetics, revealing ligand-driven conformational changes and rare unbinding pathways at a fraction of MD cost.
    Affiliations: International Digital Economy Academy

  • 🧬 MG2Act: A Mechanism-Inspired Sequential Attention Framework for Molecular Glue Degradation Prediction
    zhuang, z.; teng, d.; Xu, X.; Fang, S.; ...; Zhang, S.; Wang, X.; Zheng, M.; Qin, C. — bioRxiv, 2026-08-13
    MG2Act encodes the mechanism of molecular glues via sequential cross-attention (E3 engagement then substrate recruitment) to predict CRBN-mediated degradation, prospectively identifying nanomolar degraders including a non-classical IMiD-core CDK4 degrader.
    Affiliations: Key Laboratory of Marine Drugs, Chinese Ministry of Education

  • 📄 ScreenShot: A Foundation Model for Few-Shot Combination Drug Screening
    Antoine de Mathelin, Christopher Tosh, Wesley Tansey — arXiv, 2026-08-12
    ScreenShot is a hierarchical transformer foundation model for few-shot combination drug screening that performs in-context prediction directly from functional measurements and drives active-learning designs matching uniform screens at one-third the budget.

  • 📄 Stochastic Control Policies for Robust Molecular Transition Path Sampling
    Jingqian Liu, Yu-Hsiang Wang, Yanru Qu, Ge Liu — arXiv, 2026-08-13
    Proposes stochastic rollout-based control policies (FS-TPS, LaS-TPS) for transition path sampling that improve rare-event exploration and robustness over deterministic baselines across alanine dipeptide, chignolin, and BBL protein systems.

  • 🧬 Virtual-cell verification enables self-auditing AI discovery for immune rejuvenation
    You, Y.; Fan, X.; Li, G.; Deng, W.; ...; Kong, J.; Chen, J.; Liu, X.; Tian, L. — bioRxiv, 2026-08-11
    Builds a self-auditing AI framework with phenotype and virtual-cell verifiers plus an Analyzer–Planner–Auditor agent to validate and revise objectives for immune rejuvenation, improving module-level reversal in PBMC screens and generalizing to independent assays.
    Affiliations: Guangzhou National Laboratory

  • 📄 DegradeQuery: Counterfactual Tuple Pretraining for Context-Aware PROTAC Degradation Prediction
    Dong Xu, Zhangfan Yang, Jiantao Wu, Zexuan Zhu, Jianqiang Li, Junkai Ji — arXiv, 2026-08-11
    DegradeQuery converts label-missing molecule–target–E3 tuples into counterfactual pretraining signals for context-aware PROTAC degradation prediction, achieving state-of-the-art performance and complementing PLM features on PROTAC-8K.

  • 🧬 A comprehensive phage-bacteria interaction atlas links phage lineage and capsule serotype to genome-guided machine learning prediction in Klebsiella pneumoniae
    Selvakumar, H.; Noonan, A. J. C.; Rotman, E.; Alayouni, M.; ...; Roux, S.; Mimee, M.; Arkin, A. P.; Mutalik, V. K. — bioRxiv, 2026-08-13
    Creates a species-wide K. pneumoniae phage–host atlas and a genome-guided ML predictor (AUROC 0.882, AUPR 0.765) that identifies capsule/LPS biosynthesis and defense features via SHAP, informing cocktail design with in vivo validation constraints.
    Affiliations: Environmental Genomics and Systems Biology, Lawrence Berkeley National Laboratory; Biological Systems and Engineering, Lawrence Berkeley Nati

  • 🧬 Supervised Deep Learning for Efficient Cryo-EM Image Alignment in Drug Discovery with cryoPARES
    Sanchez-Garcia, R.; Berndt, A.; Apelbaum, A.; Reeks, J.; Williams, P. A.; Poelking, C.; Deane, C.; Saur, M. — bioRxiv, 2026-08-10
    cryoPARES leverages supervised DL trained on pre-aligned datasets to predict particle poses and prune particles, enabling near–real-time cryo-EM reconstructions and rapid ligand-bound complex determination in drug discovery pipelines.
    Affiliations: Astex Pharmaceuticals

  • 🧬 Ab initio side-chain sampling with PUD+ enables high-fidelity protein dynamics across AI-driven and classical simulations
    Wu, D.; Wang, T. — bioRxiv, 2026-08-11
    Releases PUD+, a 40M-conformation ab initio dataset emphasizing side-chain coverage, enabling ML force fields and reparameterized classical force fields that better capture protein folding, IDP dynamics, and ligand-binding behavior.
    Affiliations: Tsinghua University

  • 🧬 FrustrAI-Seq: Scaling Local Energetic Frustration to the Protein Sequence Space
    Leusch, J.-P.; Poley-Gil, M.; Fernandez-Martin, M.; Schlensok, J.; ...; Bordin, N.; Rost, B.; Parra, R. G.; Heinzinger, M. — bioRxiv, 2026-08-12
    FrustrAI-Seq predicts local energetic frustration directly from protein sequence using PLM embeddings, enabling proteome-scale frustration profiling without structures within minutes while retaining biological relevance.
    Affiliations: Helmholtz Munich

  • 📄 Is Retrieval All You Need? Assessment and Emergence of Novelty in Protein Structure Generation
    Tongyue Xu, Yijie Zhang, Mutian He, Lingdong Shen, Zhihong Liu, Tianlei Ying, Cheng Tan — arXiv, 2026-08-11
    Introduces Domain Retrieval Rate (DRR) to assess novelty in protein backbone generators and presents RetFold, a zero-training retrieval-and-linker baseline, showing much generated structure can be assembled from known domains at far lower cost.

  • 📄 Probing and steering biology across Boltz-1s trunk-diffusion boundary
    Piotr Jedryszek, Tongmeng Xie, Adam Winnifrith, Alexander Hasson, Weronika Ślesak, George Wicks, Toby Winnifrith, Oliver M. Crook — arXiv, 2026-08-11
    Dissects representations across the trunk–diffusion boundary of an AlphaFold3-class model (Boltz-1) via linear probes/SAEs and causal steering, finding geometry persists while sequence chemistry attenuates, and showing decodability need not imply causal control.

  • 🧬 bgnorm: A Generative Statistical Framework for Background Correction, Normalisation, and Quality Control in Multiplex Spatial Proteomics
    Kharbanda, M.; Tubelleza, R.; Tan, Y.; Tan, C. W.; ...; Belz, G.; Kulasinghe, A.; Salim, A.; Bhuva, D. D. — bioRxiv, 2026-08-11
    bgnorm models multiplex spatial proteomics intensities with a generative mixture of background, non-specific binding, and signal to perform background correction, QC, and normalization, yielding top marker-positivity classification across platforms.
    Affiliations: The University of Queensland

  • 📄 CytoBERT: A Foundation Model for Cytometry Data
    Syed Abdul Haseeb Qadri, Bjarne C. Hiller, Felix Blanke, Vanja Sophie Cangalovic, ..., Tom Siegl, Sebastian Bader, Thomas Kirste, Martin Becker — arXiv, 2026-08-14
    CytoBERT is an open-weight foundation model for single-cell cytometry with heterogeneous marker panels, pretrained on >50M cells to learn transferable inter-marker relationships and enable robust cross-dataset transfer learning.

  • 🧬 Protein language models and the long tail of functional diversity
    Vinod, R.; Char, S.; Amini, A. P.; Crawford, L. K.; Yang, K. K. — bioRxiv, 2026-08-14
    Shows that singleton protein sequences—often excluded from PLM training—carry learnable signal and dense domain diversity, advocating their inclusion and dataset-specific clustering for better coverage of the long tail of protein function.
    Affiliations: Microsoft Research New England

  • 🧬 LEN-Seek: Fast and scalable ligand binding-site similarity search in the latent space of an SE(3)-invariant graph VAE
    Yeo, K.; Kim, D.; Sim, J.; Lee, J. — bioRxiv, 2026-08-15
    LEN-Seek uses an SE(3)-invariant graph VAE with PLM-informed node features to embed ligand binding sites for fast latent-space similarity search, retrieving relevant templates at ~3,400× lower cost than geometric alignment.
    Affiliations: Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology

  • 🧬 Discovery of Selective Small-Molecule Ligands of SV2C by AI-Enhanced Virtual Screening and Experimental Validation
    Brueckner, A. C.; Martin, M. F.; Khuttan, S.; Shields, B.; ...; Salahpour, A.; Bucher, M. L.; Coleman, J. A.; Miller, G. W. — bioRxiv, 2026-08-16
    Combines homology modeling, MD/GaMD, and a CNN scoring function in an AI-enhanced virtual screening pipeline to discover selective SV2C ligands with micromolar affinity and isoform selectivity, validated experimentally.
    Affiliations: SandboxAQ, Palo Alto

Read more